Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × obinutuzumab × 30 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 11 Lymphoma, Non-Hodgkin 9 Lymphoma, Follicular 6 Lymphoma 5 Recurrence 4 Lymphoma, Large B-Cell, Diffuse 4 Neoplasms 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma, B-Cell 2 Burkitt Lymphoma 2 Lymphatic Diseases 1 Leukemia, Hairy Cell 1 Leukemia, B-Cell 1 Leukemia 1 Heart Failure 1 Cytokine Release Syndrome 1

Interventions

Cyclophosphamide 2 sodium-iodide symporter 1 selinexor 1 relatlimab 1 fludarabine 1 decitabine and cedazuridine drug combination 1 cemiplimab 1 belinostat 1 X-Rays 1 Specimen Handling 1 Salvage Therapy 1 Prednisone 1 Photons 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Immunoglobulin G 1 Doxorubicin 1 Disulfides 1 CTLA-4 Antigen 1 Brentuximab Vedotin 1 Biopsy 1 Azacitidine 1 Abatacept 1 ASTX-660 1 10-propargyl-10-deazaaminopterin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡